Citius Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CTXR and other ETFs, options, and stocks.About CTXR
Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite.
CEOLeonard L. Mazur
CEOLeonard L. Mazur
Employees23
Employees23
HeadquartersCranford, New Jersey
HeadquartersCranford, New Jersey
Founded2007
Founded2007
Employees23
Employees23
CTXR Key Statistics
Market cap13.47M
Market cap13.47M
Price-Earnings ratio-0.21
Price-Earnings ratio-0.21
Dividend yield—
Dividend yield—
Average volume1.89M
Average volume1.89M
High today$1.45
High today$1.45
Low today$1.16
Low today$1.16
Open price$1.26
Open price$1.26
Volume2.86M
Volume2.86M
52 Week high$5.95
52 Week high$5.95
52 Week low$0.1096
52 Week low$0.1096
People also own
Based on the portfolios of people who own CTXR. This list is generated using Robinhood data, and it’s not a recommendation.